Unknown PHASE3 INTERVENTIONAL NCT00000124

Collaborative Ocular Melanoma Study (COMS)

Sponsor: National Eye Institute (NEI)

Updated 5 times since 2017 Last updated: Jun 1, 2006 Started: Nov 30, 1986

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Choroid Neoplasms and Uveitis, this trial is ongoing. The trial is conducted by National Eye Institute (NEI) and has accumulated 5 data snapshots since 1986. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Nov 1986

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Eye Institute (NEI)

Data source: National Eye Institute (NEI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.